Myocardial beta adrenoceptors and left ventricular function in hypertrophic cardiomyopathy

被引:47
作者
Choudhury, L
Guzzetti, S
Lefroy, DC
Nihoyannopoulos, P
McKenna, WJ
Oakley, CM
Camici, PG
机构
[1] HAMMERSMITH HOSP,MRC,CYCLOTRON UNIT,LONDON W12 0HS,ENGLAND
[2] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,LONDON W12 0HS,ENGLAND
[3] ST GEORGE HOSP,SCH MED,DEPT CARDIOL SCI,LONDON SW17 0RE,ENGLAND
关键词
hypertrophic cardiomyopathy; myocardial adrenoceptors; left ventricular function; positron emission tomography;
D O I
10.1136/hrt.75.1.50
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-To assess the relation between left ventricular function and myocardial beta adrenoceptor density. Methods-17 patients with hypertrophic cardiomyopathy, six with and 11 without heart failure, were studied. Left ventricular function was assessed by echocardiography, and myocardial beta adrenoceptors by positron emission tomography. Patient data were compared with those obtained in normal controls. Results-Myocardial beta adrenoceptor density in the 17 patients was 7.00 (SD 1.90) pmol/g v 11.50 (2.18) pmol/g in normal controls (P < 0.01). beta Adrenoceptor density in the six patients with left ventricular failure was 5.61 (0.88) pmol/g v 7.71 (1.86) pmol/g in the 11 patients with normal ventricular function (P < 0.05), and there was a significant correlation (r = 0.52; P < 0.05) between left ventricular fractional shortening and myocardial beta adrenoceptor density. A positive correlation (r = 0.51; P < 0.05) was also found between myocardial beta adrenoceptor density and the E/A transmitral flow ratio, an index of left ventricular diastolic function. Conclusions-There is myocardial beta adrenoceptor downregulation in patients with hypertrophic cardiomyopathy with or without signs of heart failure.
引用
收藏
页码:50 / 54
页数:5
相关论文
共 26 条
[1]   NONINVASIVE QUANTIFICATION OF REGIONAL MYOCARDIAL BLOOD-FLOW IN CORONARY-ARTERY DISEASE WITH OXYGEN-15-LABELED CARBON-DIOXIDE INHALATION AND POSITRON EMISSION TOMOGRAPHY [J].
ARAUJO, LI ;
LAMMERTSMA, AA ;
RHODES, CG ;
MCFALLS, EO ;
IIDA, H ;
RECHAVIA, E ;
GALASSI, A ;
DESILVA, R ;
JONES, T ;
MASERI, A .
CIRCULATION, 1991, 83 (03) :875-885
[2]  
BRADY F, 1991, APPL RADIAT ISOTOPES, V42, P621
[3]   PATHOPHYSIOLOGIC AND PHARMACOLOGICAL RATIONALES FOR CLINICAL MANAGEMENT OF CHRONIC HEART-FAILURE WITH BETA-BLOCKING-AGENTS [J].
BRISTOW, MR .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (09) :C12-C22
[4]   BETA-ADRENERGIC NEUROEFFECTOR ABNORMALITIES IN THE FAILING HUMAN HEART ARE PRODUCED BY LOCAL RATHER THAN SYSTEMIC MECHANISMS [J].
BRISTOW, MR ;
MINOBE, W ;
RASMUSSEN, R ;
LARRABEE, P ;
SKERL, L ;
KLEIN, JW ;
ANDERSON, FL ;
MURRAY, J ;
MESTRONI, L ;
KARWANDE, SV ;
FOWLER, M ;
GINSBURG, R .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (03) :803-815
[5]   DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS [J].
BRISTOW, MR ;
GINSBURG, R ;
MINOBE, W ;
CUBICCIOTTI, RS ;
SAGEMAN, WS ;
LURIE, K ;
BILLINGHAM, ME ;
HARRISON, DC ;
STINSON, EB .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) :205-211
[6]   CARDIAC NOREPINEPHRINE KINETICS IN HYPERTROPHIC CARDIOMYOPATHY [J].
BRUSH, JE ;
EISENHOFER, G ;
GARTY, M ;
STULL, R ;
MARON, BJ ;
CANNON, RO ;
PANZA, JA ;
EPSTEIN, SE ;
GOLDSTEIN, DS .
CIRCULATION, 1989, 79 (04) :836-844
[7]  
Corr Laura A., 1993, Journal of the American College of Cardiology, V21, p123A
[8]  
DELFORGE J, 1991, J NUCL MED, V32, P739
[9]   PROGRESSION OF HYPERTROPHIC CARDIOMYOPATHY INTO A HYPOKINETIC LEFT-VENTRICLE - HIGHER INCIDENCE IN PATIENTS WITH MIDVENTRICULAR OBSTRUCTION [J].
FIGHALI, S ;
KRAJCER, Z ;
EDELMAN, S ;
LEACHMAN, RD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (02) :288-294
[10]   A MOLECULAR-BASIS FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - A BETA-CARDIAC MYOSIN HEAVY-CHAIN GENE MISSENSE MUTATION [J].
GEISTERFERLOWRANCE, AAT ;
KASS, S ;
TANIGAWA, G ;
VOSBERG, HP ;
MCKENNA, W ;
SEIDMAN, CE ;
SEIDMAN, JG .
CELL, 1990, 62 (05) :999-1006